Vaxxinity Stock Net Income
Vaxxinity fundamentals help investors to digest information that contributes to Vaxxinity's financial success or failures. It also enables traders to predict the movement of Vaxxinity Pink Sheet. The fundamental analysis module provides a way to measure Vaxxinity's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vaxxinity pink sheet.
Vaxxinity |
Vaxxinity Company Net Income Analysis
Vaxxinity's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Vaxxinity Net Income | (56.93 M) |
Most of Vaxxinity's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vaxxinity is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Vaxxinity reported net income of (56.93 Million). This is 116.68% lower than that of the Biotechnology sector and 181.28% lower than that of the Health Care industry. The net income for all United States stocks is 109.97% higher than that of the company.
Vaxxinity Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vaxxinity's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Vaxxinity could also be used in its relative valuation, which is a method of valuing Vaxxinity by comparing valuation metrics of similar companies.Vaxxinity is currently under evaluation in net income category among its peers.
Vaxxinity Fundamentals
| Return On Equity | -1.51 | ||||
| Return On Asset | -0.48 | ||||
| Current Valuation | (1.39 M) | ||||
| Shares Outstanding | 112.91 M | ||||
| Shares Owned By Insiders | 50.90 % | ||||
| Shares Owned By Institutions | 12.24 % | ||||
| Number Of Shares Shorted | 4.22 M | ||||
| Price To Book | 4.58 X | ||||
| Price To Sales | 4,605 X | ||||
| Gross Profit | (1.87 M) | ||||
| EBITDA | (56.05 M) | ||||
| Net Income | (56.93 M) | ||||
| Cash And Equivalents | 128.23 M | ||||
| Cash Per Share | 1.02 X | ||||
| Total Debt | 15.17 M | ||||
| Debt To Equity | 0.09 % | ||||
| Current Ratio | 5.46 X | ||||
| Book Value Per Share | 0.11 X | ||||
| Cash Flow From Operations | (57.24 M) | ||||
| Short Ratio | 13.97 X | ||||
| Earnings Per Share | (0.45) X | ||||
| Price To Earnings To Growth | 0.05 X | ||||
| Target Price | 15.0 | ||||
| Number Of Employees | 57 | ||||
| Beta | 2.4 | ||||
| Market Capitalization | 14.09 M | ||||
| Total Asset | 44.35 M | ||||
| Retained Earnings | (361.64 M) | ||||
| Working Capital | 15.62 M | ||||
| Net Asset | 44.35 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Vaxxinity Pink Sheet
If you are still planning to invest in Vaxxinity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaxxinity's history and understand the potential risks before investing.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |